Loading…
Onesource Specialty Pharma (ONESOURCE)₹1,618−0.89%Pharmaceuticals
At the end of the Sep 2026 quarter, Onesource Specialty Pharma's shareholders were: promoters 30.49%, FIIs 19.46%, DIIs 24.23%, public 25.82%. Promoter holding is down 0.01 percentage points from 30.50% a quarter earlier. FII holding is up 0.06 percentage points from 19.40% a year earlier. 37.23% of promoter shares were pledged. It had 79,780 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 37.78% | 34.27% | 29.80% | 29.79% | 29.95% | 30.50% | 30.50% | 30.49% |
| FIIs | 17.45% | 18.55% | 18.70% | 19.40% | 19.25% | 17.51% | 19.20% | 19.46% |
| DIIs | 12.59% | 18.06% | 18.12% | 18.51% | 18.83% | 20.64% | 23.40% | 24.23% |
| Public | 32.18% | 29.12% | 33.38% | 32.30% | 31.97% | 31.35% | 26.90% | 25.82% |
| Promoter shares pledged | — | — | — | — | — | — | — | 37.23% |
| Number of shareholders | 98,437 | 82,722 | 87,771 | 87,427 | 84,605 | 79,470 | 77,908 | 79,780 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Tenshi Pharmaceuticals Private Limited | Promoter | 18.45% | −0.01 |
| Karuna Business Solutions Llp | Promoter | 7.09% | 0.00 |
| Motilal Oswal Mutual Fund | DII | 7.05% | −0.04 |
| Authum Investment And Infrastructure Limited | Public | 4.91% | −0.01 |
| Sbi Life Insurance Co. Ltd | DII | 2.91% | +0.84 |
| Pronomz Ventures Llp | Promoter | 2.42% | 0.00 |
| Route One Offshore Master Fund L.P. | FII | 2.33% | 0.00 |
| Route One Fund I, L.P. | FII | 2.08% | 0.00 |
| Think Investments Pcc | Public | 1.78% | 0.00 |
| Fidelity Securities Fund: Fidelity Blue Chip Growth Fund | FII | 1.77% | 0.00 |
| 360 One Special Opportunities Fund - Series 12 | DII | 1.61% | 0.00 |
| Amansa Holdings Private Limited | FII | 1.59% | −0.28 |
| Arco Lab Private Limited | Promoter | 1.59% | 0.00 |
| Axis Mutual Fund | DII | 1.39% | +0.05 |
| 360 One Mutual Fund | DII | 1.23% | New |
| Mirae Asset | DII | 1.14% | −0.09 |
| Timf Holdings | Public | 1.04% | −0.21 |
| Arun Kumar Pillai | Promoter | 0.85% | 0.00 |
| Padmakumar Karunakaran Pillai | Promoter | 0.04% | 0.00 |
| Vineetha Mohanakumar Pillai | Promoter | 0.04% | 0.00 |
| Aditya Arun Kumar | Promoter | 0.03% | 0.00 |
| Rajitha Gopalakrishnan | Promoter | 0.03% | 0.00 |
| Sajitha Pillai | Promoter | 0.03% | 0.00 |
| Hemalatha Pillai | Promoter | 0.00% | 0.00 |
Promoters held 30.49% of Onesource Specialty Pharma at the end of the Sep 2026 quarter, up 0.70 percentage points from 29.79% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 19.46% (up 0.26 percentage points from 19.20% a quarter earlier) and domestic institutions (DIIs) held 24.23% (up 0.83 percentage points from 23.40% a quarter earlier).
Yes. 37.23% of promoter shares were pledged at the end of the Sep 2026 quarter.
Onesource Specialty Pharma had 79,780 shareholders at the end of the Sep 2026 quarter, against 87,427 a year earlier.
Motilal Oswal Mutual Fund (DII) held 7.05% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.